Tetrault Lynn A.'s Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Jun 24, 2026
- Accession no.
- 0001104659-26-077305
- Filed
- Jun 24, 2026
- Trade date
- Jun 22, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.71M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tetrault Lynn A.CIK 0001645512 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | MOption exerciseAcquired | +37,000 | $28.27 | +$1,045,990 | 44,000 | Direct | |
| Jun 22, 2026 | Common Stock | SSaleDisposed | −37,000 | $100.32 | −$3,711,840 | 7,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | MOption exerciseDisposed | −37,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.